# CART Therapy in GUCY2C-positive Digestive Tract Tumors

> **NCT04652219** · EARLY_PHASE1 · COMPLETED · sponsor: **Weijia Fang, MD** · enrollment: 1 (actual)

## Conditions studied

- Malignant Neoplasms of Digestive Organs

## Interventions

- **BIOLOGICAL:** gucy2c cart cells

## Key facts

- **NCT ID:** NCT04652219
- **Lead sponsor:** Weijia Fang, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-10
- **Primary completion:** 2021-10-09
- **Final completion:** 2021-10-09
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2023-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04652219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04652219, "CART Therapy in GUCY2C-positive Digestive Tract Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04652219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*